These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series. Menè P; Giammarioli E; Fofi C; Antolino G; Verde G; Tafuri A; Punzo G; Festuccia F Kidney Blood Press Res; 2018; 43(4):1263-1272. PubMed ID: 30078004 [TBL] [Abstract][Full Text] [Related]
44. p66SHC-mediated mitochondrial dysfunction in renal proximal tubule cells during oxidative injury. Arany I; Faisal A; Clark JS; Vera T; Baliga R; Nagamine Y Am J Physiol Renal Physiol; 2010 May; 298(5):F1214-21. PubMed ID: 20053790 [TBL] [Abstract][Full Text] [Related]
45. Novel approaches for reducing free light chains in patients with myeloma kidney. Hutchison CA; Bladé J; Cockwell P; Cook M; Drayson M; Fermand JP; Kastritis E; Kyle R; Leung N; Pasquali S; Winearls C; Nat Rev Nephrol; 2012 Feb; 8(4):234-43. PubMed ID: 22349488 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy. Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542 [TBL] [Abstract][Full Text] [Related]
55. Current approach to diagnosis and management of acute renal failure in myeloma patients. Leung N; Behrens J Adv Chronic Kidney Dis; 2012 Sep; 19(5):297-302. PubMed ID: 22920640 [TBL] [Abstract][Full Text] [Related]
56. Light chain proximal tubulopathy without crystals in a case of Burkitt lymphoma presenting with acute kidney injury. Rane S; Rana S; Sachdeva M; Joshi K Am J Kidney Dis; 2013 Sep; 62(3):638-41. PubMed ID: 23523237 [TBL] [Abstract][Full Text] [Related]
57. Comparison of free light chain removal by four blood purification methods. Kanayama K; Ohashi A; Hasegawa M; Kondo F; Yamamoto Y; Sasaki M; Hayashi H; Kato M; Hattori R; Yamashita H; Arai J; Ishii J; Emi N; Yuzawa Y Ther Apher Dial; 2011 Aug; 15(4):394-9. PubMed ID: 21884475 [TBL] [Abstract][Full Text] [Related]
58. Renal failure in myeloma: relationship with isoelectric point of immunoglobulin light chains. Melcion C; Mougenot B; Baudouin B; Ronco P; Moulonguet-Doleris L; Vanhille P; Beaufils M; Morel-Maroger L; Verroust P; Richet G Clin Nephrol; 1984 Sep; 22(3):138-43. PubMed ID: 6435919 [TBL] [Abstract][Full Text] [Related]
59. [Biochemical and immunological findings of multiple myeloma]. Asaoku H Nihon Rinsho; 2007 Dec; 65(12):2256-60. PubMed ID: 18069270 [TBL] [Abstract][Full Text] [Related]
60. The double polymethylmethacrylate filter (DELETE system) in the removal of light chains in chronic dialysis patients with multiple myeloma. Santoro A; Grazia M; Mancini E Blood Purif; 2013; 35 Suppl 2():5-13. PubMed ID: 23676829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]